T2 Biosystems, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q3 2024.

Symbol
TTOO on OTC
Location
Lexington, MA
Fiscal year end
31 December
Latest financial report
14 Nov 2024

Quick Takeaways

  • TTOO - T2 Biosystems, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q3 2024.
  • Headline metric: Return On Equity 278%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+42%</span>.
  • Most recent SEC facts end date: 11 Nov 2024.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2024-11-11) highlights Return On Equity 277.6%, Return On Assets -140.0%, and Operating Margin -542.6%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

36.8/100

Weak Confidence high

Return On Equity

278%

Metric score 100.0/100

Return On Assets

-140%

Metric score 0.0/100

Financial Health

Current Ratio
0.4x
Quick Ratio
0.17x
Debt to Equity
-2.19x

Strengths

Return On Equity and NetIncomeLoss YoY

Watchpoints

Return On Assets, Operating Margin, and Quick Ratio

Key metrics snapshot

Return On Equity

278%

YoY: +42%

Industry median: -17% (n=179)

View history

Return On Assets

-140%

YoY: +23%

Industry median: -34% (n=178)

View history

Operating Margin

-543%

YoY: +20%

Industry median: -18% (n=127)

View history

Current Ratio

0.4x

YoY: -32%

Industry median: 2.36x (n=176)

View history

Quick Ratio

0.17x

YoY: -63%

Industry median: 1.49x (n=146)

View history

Debt-to-equity

-2.19x

YoY: +8.7%

Industry median: 0.46x (n=133)

View history

Revenues YoY

-30%

YoY:

Industry median: 15% (n=128)

View history

NetIncomeLoss YoY

14%

YoY:

Industry median: 0.49% (n=168)

View history

Profitability

Metric Latest value YoY change
Return On Equity 278% +42%
Return On Assets -140% +23%
Operating Margin -543% +20%

Financial Health

Metric Latest value YoY change
Current Ratio 0.4x -32%
Quick Ratio 0.17x -63%
Debt-to-equity -2.19x +8.7%

Growth

Metric Latest value YoY change
Revenues YoY -30%
NetIncomeLoss YoY 14%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 21,042,952 +420%
Common Stock, Shares, Outstanding 18,760,092 +379%
Common Stock, Value, Issued $18,000 +350%
Weighted Average Number of Shares Outstanding, Basic 17,892,606 +300%
Weighted Average Number of Shares Outstanding, Diluted 17,892,606 +300%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $7,677,000 -30%
Research and Development Expense $12,918,000 -17%
Costs and Expenses $49,332,000 -19%
Operating Income (Loss) $41,655,000 +16%
Nonoperating Income (Expense) $1,299,000 -4579%
Earnings Per Share, Basic 120 +83%
Earnings Per Share, Diluted 120 +83%
Cash and Cash Equivalents, at Carrying Value $2,083,000 -91%
Accounts Receivable, after Allowance for Credit Loss, Current $2,033,000 +78%
Inventory, Net $3,825,000 -11%
Assets, Current $9,786,000 -70%
Property, Plant and Equipment, Net $1,477,000 -28%
Operating Lease, Right-of-Use Asset $6,268,000 -19%
Assets $18,082,000 -58%
Accounts Payable, Current $4,210,000 +287%
Employee-related Liabilities, Current $3,412,000 +5.6%
Accrued Liabilities, Current $4,627,000 -6.6%
Contract with Customer, Liability, Current $233,000 -16%
Liabilities, Current $24,435,000 -56%
Contract with Customer, Liability, Noncurrent $59,000 +48%
Operating Lease, Liability, Noncurrent $5,298,000 -25%
Liabilities $29,792,000 -52%
Retained Earnings (Accumulated Deficit) $616,910,000 -7.5%
Stockholders' Equity Attributable to Parent $11,710,000 +39%
Liabilities and Equity $18,082,000 -58%
Common Stock, Shares Authorized 400,000,000 0%
Common Stock, Shares, Issued 18,760,092 +379%
Common Stock, Par or Stated Value Per Share 0 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2,600,000
Property, Plant and Equipment, Gross $16,481,000 -2.5%
Operating Lease, Liability, Current $1,724,000 +11%
Preferred Stock, Shares Issued 0 -100%
Preferred Stock, Shares Authorized 10,000,000 0%
Preferred Stock, Shares Outstanding 0 -100%
Share-based Payment Arrangement, Expense $2,802,000 -39%
Preferred Stock, Par or Stated Value Per Share 0 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY